Small cars and two-wheelers face demand pain: Sudip Bandyopadhyay
ET Now: Why we are talking about pharma, Sharan just said that Trump is actually doing everything he has promised and earlier he has also at least warned the street about a 200% of tariff. To what extent do you think that could actually turn to fruition, anything that can happen on that front, where are you seeing the impact on our pharma sector back home?
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
Sudip Bandyopadhyay, Group Chairman, Inditrade Capital , says the small cars as well as two-wheeler there is a challenge, and we know that, there was a demand constraints and everybody was talking about that. We are hoping that festive season, post monsoon things will improve.Well, pretty much it is in line with the expectation I would say, at least that is what we were pencilling in. We were reasonably sure that the commercial vehicle numbers would be in line and better and improving and that is pretty much what the Ashok Leyland numbers shows. Even if you look at Eicher Motors , their commercial vehicle part does show promise and improvement. As far as domestic two-wheeler sales are concerned, obviously, it is subdued. Look at the Bajaj numbers. They are really bad. Of course, Bajaj has a fantastic export performance which takes care and that is why the overall numbers for Bajaj still looks better. But the small cars as well as two-wheeler there is a challenge, and we know that, there was a demand constraints and everybody was talking about that. We are hoping that festive season, post monsoon things will improve. We will have to wait and watch, that is pretty much what it is. As things stand today, there is a problem as far as demand for small cars as well as two wheelers.Well, one thing is very sure that as long as Mr Trump is the president, volatility is the order of the day and we have to be bracing ourselves for that. Every day there is something new and some new tweet comes in or some communication, an interview comes in which kind of rattles the market and that is the order of the day. As far as pharma is concerned, putting a tariff 200% or otherwise is not a viable proposition for us and the consumers which Trump is trying to protect. So, he will not venture there. But yesterday's and today's initiative where he has written to the pharma company CEOs to bring down the prices in US, that is a threat definitely and some of the Indian companies who have large business in US definitely will be impacted. If he carries out some other measure, some other punitive measure, or some other steps he takes to ensure that his communication is adhered to, that is a matter of big concern and worry. So, under these circumstances, and this view I have been maintaining for some time, it is better to be a little careful about companies having significant exposure in the US market and focus on companies who have less or no exposure as far as US markets are concerned. So, we were just talking about Mankind Pharma , that is one company which has got 95% of the sales in India and results were decent. So, one can focus on companies like this who have got a significant domestic presence and limited US presence.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
23 minutes ago
- Business Standard
Adani Group stocks trade weak; Adani Green, Power, Enterprises down upto 3%
Adani Group stocks in focus: Shares of Adani Group companies were under pressure, falling by up to 3 per cent on the BSE in Thursday's intra-day trade due to overall weakness in the equity market. Indian equity indices were trading lower on Thursday after US President Donald Trump imposed an additional 25 per cent tariff on Indian exports to the US, citing New Delhi's continued purchases of Russian crude oil. Adani Green Energy, Adani Ports and Special Economic Zone, Adani Enterprises, Adani Power, ACC and Adani Energy Solutions were down in the range of 1 per cent to 3 per cent on the BSE in intra-day trade. By comparison, the BSE Sensex was down 0.61 per cent at 80,050 at 11:10 AM. CATCH STOCK MARKET LIVE UPDATES TODAY In the past one month, these stocks have underperformed the market by falling between 6 per cent and 12 per cent, as against 4 per cent decline in the benchmark index. Among the individual stocks, Adani Enterprises has slipped 2.6 per cent to ₹2,240.20 in intra-day trade today. The stock price of Adani Group flagship company is quoting at its lowest level since May 9, 2025. In the past month, the stock has corrected 12 per cent. For April to June 2025 quarter (Q1FY26), Adani Enterprises reported a 50 per cent year-on-year (Y-o-Y) decline in its consolidated profit after tax at ₹734 crore, against ₹1,458 crore in Q1FY25. Consolidated earnings before interest, tax, depreciation, and amortisation (Ebitda) down 12 per cent Y-o-Y to ₹3,786 crore. Total income decreased 14 per cent Y-o-Y at ₹22,437 crore. However, the company's Ebitda from incubating businesses has increased by 5 per cent to ₹2,800 crore on Y-o-Y basis and contributes 74 per cent to Q1FY26 results. Adani Enterprises said the company shall witness operationalization of the large infra assets during this fiscal year reflecting its project execution capabilities, which should result in Ebitda unlock and long-term value creation. This performance has been led by the company's Airports business, which delivered an exceptional 61 per cent Y-o-Y growth in Ebitda. Meanwhile, global economic growth is expected to moderate from 3.3 per cent in 2024 to 2.8 per cent in 2025, before recovering to 3 per cent in 2026. The combined effects of new trade restrictions, their spillover through global trade linkages, and rising uncertainty may dampen business sentiment and pace of economic recovery. Financial market volatility has raised concerns about extreme vulnerabilities, particularly in countries grappling with persistent inflation and signs of economic slowdown, Adani Enterprises said in its FY25 annual report. Meanwhile, shares of Adani Energy Solutions were down 2 per cent to ₹778.25 on the BSE in intra-day trade. In the past two trading days, the stock declined 3 per cent as Abu Dhabi-based Envestcom Holding RSC Ltd offloaded 22 million shares of Adani Energy Solutions on Wednesday, via open market, according to bulk deal data from the exchanges. While 11 million shares were sold on the NSE, the remaining 10.98 million shares were offloaded on the BSE at an average price of ₹790 per share, data shows. The names of buyers are not ascertained immediately. As of June 2025, Envestcom held 32.18 million shares or 2.68 per cent stake in Adani Energy Solutions, the shareholding pattern data shows. Meanwhile, shares of Adani Power has moved higher by 2 per cent to Rs 565.80 from its intra-day low after the company said it will set up a 2,400 MW ultra-supercritical power plant at Village Pirpainti in Bhagalpur district of Bihar at an investment of up to $3 billion and supply the entire net capacity of 2,274 MW to Bihar Utilities. Adani Power said the company has received a Letter of Intent (LoI) from Bihar State Power Generation Company (BSPGCL) to supply 2,274 MW power to North Bihar Power Distribution Company (NBPDCL) and South Bihar Power Distribution Company (SBPDCL) from a 2,400 MW thermal power project to be developed at Pirpainti in Bhagalpur District of Bihar.
&w=3840&q=100)
Business Standard
23 minutes ago
- Business Standard
Trump's tariff hike could shave 0.3 pp off India's GDP: Goldman Sachs
India condemns new 25% duty on exports; total levy now at 50%; analysts expect talks before August 27 deadline New Delhi India's economy could take an additional 0.3 percentage point (pp) annualised hit to real gross domestic product (GDP) growth following US President Donald Trump's decision to impose a fresh 25 per cent duty on Indian imports, Goldman Sachs said. This is over and above the 0.3 pp impact previously estimated from the April 2025 tariff round. According to Goldman Sachs, once exclusions, such as those under Section 232 of the US Trade Expansion Act, 1962, are applied, the effective average tariff rate on Indian exports to the US will settle at around 32 per cent. US doubles tariff on Indian goods On Wednesday evening, Trump issued an executive order imposing an additional 25 per cent duty on Indian imports. This brings the total levy to 50 per cent, effective August 27. India's US exposure significant India's exposure to the US market is substantial. Around 4 per cent of India's GDP is linked to final demand from the United States, Goldman Sachs analysts noted. In FY25, India exported goods worth $86.5 billion to the US, while imports stood at $45.7 billion. Key exports include electronics, chemicals, pharmaceuticals, and textiles, while major imports are crude oil, gems and jewellery, and machinery. Russian crude oil: A flashpoint in India-US trade relations One major point of tension is oil. While Russia provided about one-third of India's crude oil in FY25, the US share was just 4 per cent. That share did rise to 8 per cent in April and May 2025, but the US remains a minor supplier overall. MEA terms move 'unfair' India's Ministry of External Affairs (MEA) called the US action ' unfair, unjustified, and unreasonable.' It said India's energy sourcing was guided by market pricing and supply security. 'It is extremely unfortunate that the US has chosen to penalise India for decisions being made by several other countries in their own national interest,' the MEA said in a strongly worded statement. PM Modi: Farmers, fishers, dairy will not be sacrificed Addressing the MS Swaminathan Centenary International Conference on Thursday, Prime Minister Narendra Modi asserted that India would not compromise on the interests of its farmers, fishers, or dairy industry. ' The interest of our farmers is our top priority … I know that I will have to pay a heavy personal price for this. But I am ready for it,' the Prime Minister said. Room for negotiations remains Goldman Sachs has not revised its India GDP forecast yet, but flagged the possibility of further impact if retaliatory actions or broader trade restrictions follow. 'There is a window for negotiation,' the report said, pointing to the three-week gap before the new tariffs come into effect. A day earlier, the Reserve Bank of India (RBI) held its FY26 GDP growth projection steady at 6.5 per cent, citing a lack of sufficient data to warrant revisions. RBI Governor Sanjay Malhotra, speaking after the Monetary Policy Committee (MPC) meeting, said, ' We do not have sufficient data to revise our GDP forecast,' adding that global uncertainties had already been factored into earlier projections.
Mint
23 minutes ago
- Mint
Renol Polychem IPO listing: Renol Polychem share price makes flat debut on NSE SME, tanks 5% to hit lower circuit
Renol Polychem IPO listing: Renol Polychem share price debuted flat on the NSE SME on Thursday, August 7, amid weak market sentiment on worries over Trump tariffs. Renol Polychem stock opened at par its issue price of ₹ 105. After a flat opening, the stock saw a sharp selloff which dragged it its 5 per cent lower circuit of ₹ 99.75. Around 11:10 AM, the stock was locked in its 5 per cent lower circuit. The stock's listing was below what the grey market was expecting. As per grey market sources, the stock was expected to list at ₹ 108. Renol Polychem supplies a diverse range of raw materials, including colour masterbatches, pigments, filler granules, anti-moisture powders, carbon noodles, superpack and onepack solutions, impact modifiers, processing aids, and titanium dioxide. Operating on a B2B model, the company serves industrial and commercial clients exclusively, providing essential inputs for the manufacturing of plastic products. The company specialises in manufacturing tailor-made masterbatches and pigment solutions designed to meet specific performance, colour, and application requirements of customers. Renol Polychem IPO opened for subscription on Thursday, July 31 and closed on Monday, August 4. The ₹ 25.77 crore SME IPO, which was a fresh issue of 24.54 lakh shares, was priced at ₹ 100-105 per share. Renol Polychem IPO was subscribed 6.83 times. The retail category was booked 6.51 times, while the non-institutional investor (NII) quota was subscribed 6.89 times. The qualified institutional buyer (QIB) segment was booked 8.41 times. The company intends to use the net proceeds from the IPO to fund capital expenditure for machinery purchases, meet working capital requirements, repay some borrowings, and for general corporate purposes. Read all IPO-related news here Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of individual analysts or broking firms, not Mint. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.
